Effectiveness of structured lactation support and human donor milk banking in German NICUs: a stepped-wedge cluster-randomized trial.

IF 8.7 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Juliane Köberlein-Neu, Nicola Gabriela Dymek, Viola Zimmer, Trutz Bommhardt, Anna Katharina Stirner, Isabella Güldenring, Tim Ohnhäuser, Daniel Wiesen, Till Dresbach, Nadine Scholten
{"title":"Effectiveness of structured lactation support and human donor milk banking in German NICUs: a stepped-wedge cluster-randomized trial.","authors":"Juliane Köberlein-Neu, Nicola Gabriela Dymek, Viola Zimmer, Trutz Bommhardt, Anna Katharina Stirner, Isabella Güldenring, Tim Ohnhäuser, Daniel Wiesen, Till Dresbach, Nadine Scholten","doi":"10.1186/s12916-026-05211-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Although exclusive human milk feeding is beneficial for very low birth weight infants, rates remain suboptimal globally. This hybrid type 1 effectiveness-implementation trial evaluated structured lactation support combined with human donor milk banking in neonatal intensive care units (NICUs), primarily assessing effectiveness, with secondary assessment of implementation and economic outcomes.</p><p><strong>Methods: </strong>We conducted a stepped-wedge cluster-randomized trial in 15 German Level I NICUs (April 2022-March 2024). The Neo-MILK intervention comprised structured lactation counselling, multilingual materials, mobile app support for mothers/parents, and human donor milk banking. Implementation strategies included video-based staff training, guidelines, commitment nudges for medical staff, and support for human donor milk bank establishment. The primary outcome was exclusive mother's own milk feeding at NICU discharge. Secondary outcomes included feeding status categories, clinical complications, length of stay, and maternal outcomes. Implementation outcomes were acceptability, feasibility, appropriateness, fidelity, and sustainability. Prespecified subgroup analyses examined birth weight (< 1,000 g vs. ≥1,000 g) and illness severity (CRIB ≥ 11 vs. <11). Economic evaluation employed time-driven activity-based costing and budget impact analysis.</p><p><strong>Results: </strong>Among 1,627 very low birth weight infants (831 intervention, 796 control), the intervention increased exclusive mother's own milk feeding at discharge by 11%-points (95% CI: 3.0 to 19.0; p = 0.007) from a 43% baseline. Exclusive formula feeding decreased correspondingly. Subgroup analyses showed no significant effects in extremely low birth weight infants (< 1,000 g) or high-risk infants (CRIB ≥ 11). Clinical complications and length of stay showed no differences. Acceptability, appropriateness, and feasibility were high. Fidelity was sufficient, with prepartal counselling delivered as intended in 71% of cases. Human donor milk banks were established in 40% of sites. Sustainability indicators were promising, with 61% of staff reporting routine integration. Economic evaluation suggested potential net savings nationally in the base-case scenario.</p><p><strong>Conclusions: </strong>Structured lactation support with human donor milk banking increased exclusive mother's own milk feeding across Level I NICUs, with no observed increase in complications or costs. Implementation appeared feasible, with indications of sustainability. Variable uptake and differential effects in highest-risk subgroups highlight the need for ongoing organizational support and tailored strategies to further optimize effectiveness.</p><p><strong>Clinical trial registration: </strong>German Clinical Trials Register DRKS00025058.</p>","PeriodicalId":9188,"journal":{"name":"BMC Medicine","volume":"24 1","pages":""},"PeriodicalIF":8.7000,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13587408/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12916-026-05211-1","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Although exclusive human milk feeding is beneficial for very low birth weight infants, rates remain suboptimal globally. This hybrid type 1 effectiveness-implementation trial evaluated structured lactation support combined with human donor milk banking in neonatal intensive care units (NICUs), primarily assessing effectiveness, with secondary assessment of implementation and economic outcomes.

Methods: We conducted a stepped-wedge cluster-randomized trial in 15 German Level I NICUs (April 2022-March 2024). The Neo-MILK intervention comprised structured lactation counselling, multilingual materials, mobile app support for mothers/parents, and human donor milk banking. Implementation strategies included video-based staff training, guidelines, commitment nudges for medical staff, and support for human donor milk bank establishment. The primary outcome was exclusive mother's own milk feeding at NICU discharge. Secondary outcomes included feeding status categories, clinical complications, length of stay, and maternal outcomes. Implementation outcomes were acceptability, feasibility, appropriateness, fidelity, and sustainability. Prespecified subgroup analyses examined birth weight (< 1,000 g vs. ≥1,000 g) and illness severity (CRIB ≥ 11 vs. <11). Economic evaluation employed time-driven activity-based costing and budget impact analysis.

Results: Among 1,627 very low birth weight infants (831 intervention, 796 control), the intervention increased exclusive mother's own milk feeding at discharge by 11%-points (95% CI: 3.0 to 19.0; p = 0.007) from a 43% baseline. Exclusive formula feeding decreased correspondingly. Subgroup analyses showed no significant effects in extremely low birth weight infants (< 1,000 g) or high-risk infants (CRIB ≥ 11). Clinical complications and length of stay showed no differences. Acceptability, appropriateness, and feasibility were high. Fidelity was sufficient, with prepartal counselling delivered as intended in 71% of cases. Human donor milk banks were established in 40% of sites. Sustainability indicators were promising, with 61% of staff reporting routine integration. Economic evaluation suggested potential net savings nationally in the base-case scenario.

Conclusions: Structured lactation support with human donor milk banking increased exclusive mother's own milk feeding across Level I NICUs, with no observed increase in complications or costs. Implementation appeared feasible, with indications of sustainability. Variable uptake and differential effects in highest-risk subgroups highlight the need for ongoing organizational support and tailored strategies to further optimize effectiveness.

Clinical trial registration: German Clinical Trials Register DRKS00025058.

结构化哺乳支持和人供乳库在德国新生儿重症监护病房的有效性:一项楔步聚类随机试验。
背景:虽然纯母乳喂养对极低出生体重婴儿有益,但在全球范围内,母乳喂养率仍不理想。本混合1型有效性-实施试验评估了新生儿重症监护病房(nicu)的结构化哺乳支持与人类供体母乳库相结合,主要评估了有效性,并对实施和经济结果进行了二次评估。方法:我们在15个德国I级新生儿重症监护病房(2022年4月- 2024年3月)进行了一项楔形分组随机试验。Neo-MILK干预包括结构化哺乳咨询、多语言材料、为母亲/父母提供移动应用程序支持和人类捐赠母乳银行。实施战略包括基于视频的工作人员培训、指导方针、对医务人员的承诺推动,以及支持建立人类捐献母乳库。主要结局为新生儿重症监护病房出院时纯母乳喂养。次要结局包括喂养状况类别、临床并发症、住院时间和产妇结局。实施结果为可接受性、可行性、适当性、保真度和可持续性。预先指定的亚组分析检查了出生体重(结果:在1,627名极低出生体重婴儿中(干预组831名,对照组796名),干预组在43%的基线基础上增加了11%的纯母乳喂养(95% CI: 3.0至19.0;p = 0.007)。纯配方奶喂养相应减少。亚组分析显示,对极低出生体重儿无显著影响(结论:人类供体母乳库的结构化哺乳支持增加了一级新生儿重症监护病房的纯母乳喂养,未观察到并发症或费用的增加。执行看来是可行的,并有可持续性的迹象。在最高风险亚组中,不同的吸收和不同的效果突出了需要持续的组织支持和量身定制的战略,以进一步优化有效性。临床试验注册:德国临床试验注册DRKS00025058。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Medicine
BMC Medicine 医学-医学:内科
CiteScore
13.10
自引率
1.10%
发文量
435
审稿时长
4-8 weeks
期刊介绍: BMC Medicine is an open access, transparent peer-reviewed general medical journal. It is the flagship journal of the BMC series and publishes outstanding and influential research in various areas including clinical practice, translational medicine, medical and health advances, public health, global health, policy, and general topics of interest to the biomedical and sociomedical professional communities. In addition to research articles, the journal also publishes stimulating debates, reviews, unique forum articles, and concise tutorials. All articles published in BMC Medicine are included in various databases such as Biological Abstracts, BIOSIS, CAS, Citebase, Current contents, DOAJ, Embase, MEDLINE, PubMed, Science Citation Index Expanded, OAIster, SCImago, Scopus, SOCOLAR, and Zetoc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书